CryoCell Financial Statements From 2010 to 2025

CCEL Stock  USD 7.84  0.05  0.63%   
CryoCell International financial statements provide useful quarterly and yearly information to potential CryoCell International investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on CryoCell International financial statements helps investors assess CryoCell International's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CryoCell International's valuation are summarized below:
Gross Profit
19.7 M
Profit Margin
(0.28)
Market Capitalization
63.2 M
Enterprise Value Revenue
2.2869
Revenue
31.8 M
There are over one hundred nineteen available fundamental signals for CryoCell International, which can be analyzed over time and compared to other ratios. We recommend to validate CryoCell International's prevailing fundamental drivers against the all of the trends between 2010 and 2025. The value of Market Cap is estimated to slide to about 29 M. The Enterprise Value is projected to slide to about 60.2 M

CryoCell International Total Revenue

18.36 Million

Check CryoCell International financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CryoCell International's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Selling General Administrative of 11.2 M or Total Revenue of 18.4 M, as well as many indicators such as Price To Sales Ratio of 1.56, Dividend Yield of 0.2 or Days Sales Outstanding of 79.26. CryoCell financial statements analysis is a perfect complement when working with CryoCell International Valuation or Volatility modules.
  
Check out the analysis of CryoCell International Correlation against competitors.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.

CryoCell International Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets73.9 M70.4 M39.1 M
Slightly volatile
Other Current LiabilitiesM5.7 M3.5 M
Slightly volatile
Total Current Liabilities25.2 M24 M15.4 M
Slightly volatile
Property Plant And Equipment Net26.6 M25.3 MM
Slightly volatile
Accounts Payable3.8 M3.7 M1.8 M
Slightly volatile
Cash443.6 K467 K3.7 M
Pretty Stable
Non Current Assets Total62.5 M59.5 M27.1 M
Slightly volatile
Non Currrent Assets Other7.6 M7.3 M4.6 M
Slightly volatile
Cash And Short Term Investments1.1 M1.1 M4.1 M
Pretty Stable
Net Receivables7.9 M7.6 M5.2 M
Slightly volatile
Common Stock Shares Outstanding7.8 M7.5 M8.6 M
Slightly volatile
Liabilities And Stockholders Equity73.9 M70.4 M39.1 M
Slightly volatile
Non Current Liabilities Total62.1 M59.1 M31.3 M
Slightly volatile
Other Stockholder Equity21.5 M23 M19.4 M
Very volatile
Total Liabilities87.2 M83.1 M46.7 M
Slightly volatile
Total Current Assets10.5 M10.9 M11.9 M
Pretty Stable
Intangible AssetsM1.1 M2.6 M
Slightly volatile
Short and Long Term Debt Total9.3 M9.8 M6.8 M
Slightly volatile
Other Current Assets871.7 K1.3 M856.4 K
Very volatile
Short Term Debt1.6 M1.9 M1.7 M
Slightly volatile
Short Term Investments641.7 K516.8 K605.6 K
Slightly volatile
Common Stock134.7 K170.8 K133.7 K
Slightly volatile
Other Liabilities45.9 M43.7 M25.1 M
Slightly volatile
Other Assets28.6 M27.2 M15.1 M
Slightly volatile
Long Term Debt5.2 M9.7 M5.5 M
Slightly volatile
Property Plant Equipment17.2 M16.3 M5.9 M
Slightly volatile
Common Stock Total Equity140.6 K156.8 K131.4 K
Slightly volatile
Capital Surpluse34.8 M42.1 M33.2 M
Slightly volatile
Non Current Liabilities Other785.9 K827.3 K7.1 M
Slightly volatile
Inventory657.4 K692 K1.7 M
Very volatile
Short and Long Term Debt2.4 M1.6 M1.6 M
Slightly volatile
Capital Stock156.2 K170.8 K142.4 K
Slightly volatile

CryoCell International Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.1 MM978.8 K
Slightly volatile
Selling General Administrative11.2 M19.7 M13.8 M
Slightly volatile
Total Revenue18.4 M36 M24.9 M
Slightly volatile
Gross Profit27.7 M26.3 M18.8 M
Slightly volatile
Other Operating Expenses52.7 M50.2 M26.9 M
Slightly volatile
Cost Of Revenue5.6 M9.7 MM
Slightly volatile
Total Operating Expenses42.5 M40.5 M19.6 M
Slightly volatile
Research Development1.4 M1.3 M389.7 K
Slightly volatile
Interest Expense1.2 M1.4 M1.2 M
Slightly volatile
Reconciled DepreciationMM781.2 K
Slightly volatile

CryoCell International Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation2.1 MM877.5 K
Slightly volatile
Other Non Cash Items20.1 M19.2 M5.5 M
Slightly volatile
Capital Expenditures9.2 M8.8 M3.8 M
Slightly volatile
Total Cash From Operating Activities10.8 M10.3 M5.9 M
Slightly volatile
End Period Cash Flow443.6 K467 K3.7 M
Pretty Stable
Begin Period Cash Flow1.9 MM4.4 M
Very volatile
Stock Based Compensation616.4 K939.1 K677.6 K
Very volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.561.642.2819
Slightly volatile
Dividend Yield0.20.190.1929
Slightly volatile
Days Sales Outstanding79.2688.0773.7364
Pretty Stable
Operating Cash Flow Per Share1.010.960.6852
Slightly volatile
Average Payables2.3 M2.2 M1.5 M
Slightly volatile
Stock Based Compensation To Revenue0.02790.030.0276
Pretty Stable
Capex To Depreciation4.224.022.5956
Slightly volatile
EV To Sales1.922.022.3655
Slightly volatile
Inventory Turnover11.7312.6310.0274
Slightly volatile
Days Of Inventory On Hand36.3238.2380.0979
Very volatile
Payables Turnover2.913.064.5895
Very volatile
Sales General And Administrative To Revenue0.580.620.5791
Slightly volatile
Average Inventory885 K931.6 K2.1 M
Very volatile
Research And Ddevelopement To Revenue0.04080.0430.0434
Slightly volatile
Capex To Revenue0.170.280.1186
Slightly volatile
Cash Per Share0.10.110.4882
Very volatile
POCF Ratio4.284.514.5597
Slightly volatile
Capex To Operating Cash Flow0.580.980.4759
Slightly volatile
Days Payables Outstanding98.1515890.0323
Pretty Stable
EV To Operating Cash Flow6.757.1114.8943
Slightly volatile
Intangibles To Total Assets0.03260.04310.0709
Slightly volatile
Current Ratio0.490.521.01
Slightly volatile
Receivables Turnover7.565.485.2962
Slightly volatile
Graham Number5.515.252.8758
Slightly volatile
Capex Per Share0.870.820.423
Slightly volatile
Average ReceivablesM5.7 M4.9 M
Slightly volatile
Revenue Per Share3.553.382.9656
Slightly volatile
Interest Debt Per Share1.591.671.0158
Slightly volatile
Debt To Assets0.190.20.2016
Very volatile
Operating Cycle86.198.84139
Very volatile
Days Of Payables Outstanding98.1515890.0323
Pretty Stable
Price To Operating Cash Flows Ratio4.284.514.5597
Slightly volatile
Quick Ratio0.450.480.9098
Slightly volatile
Cash Ratio0.02130.02240.3959
Slightly volatile
Operating Cash Flow Sales Ratio0.270.260.2228
Slightly volatile
Days Of Inventory Outstanding36.3238.2380.0979
Very volatile
Days Of Sales Outstanding79.2688.0773.7364
Pretty Stable
Fixed Asset Turnover1.221.2812.2433
Slightly volatile
Price Cash Flow Ratio4.284.514.5597
Slightly volatile
Debt Ratio0.190.20.2016
Very volatile
Price Sales Ratio1.561.642.2819
Slightly volatile
Asset Turnover0.70.460.8927
Slightly volatile
Gross Profit Margin0.560.660.7149
Slightly volatile

CryoCell International Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap29 M40.2 M46.1 M
Slightly volatile
Enterprise Value60.2 M63.4 M51.4 M
Slightly volatile

CryoCell Fundamental Market Drivers

Cash And Short Term Investments980.2 K

CryoCell Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
30th of November 2023
Next Fiscal Quarter End
View

About CryoCell International Financial Statements

CryoCell International investors utilize fundamental indicators, such as revenue or net income, to predict how CryoCell Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue11.2 M6.4 M
Total Revenue36 M18.4 M
Cost Of Revenue9.7 M5.6 M
Stock Based Compensation To Revenue 0.03  0.03 
Sales General And Administrative To Revenue 0.62  0.58 
Research And Ddevelopement To Revenue 0.04  0.04 
Capex To Revenue 0.28  0.17 
Revenue Per Share 3.38  3.55 
Ebit Per Revenue(0.35)(0.37)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether CryoCell International is a strong investment it is important to analyze CryoCell International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CryoCell International's future performance. For an informed investment choice regarding CryoCell Stock, refer to the following important reports:
Check out the analysis of CryoCell International Correlation against competitors.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.625
Earnings Share
(1.07)
Revenue Per Share
3.89
Quarterly Revenue Growth
0.025
Return On Assets
(0)
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.